FDA inspection

Topharman Shandong Co., Ltd.: FDA inspection ending Sep 28, 2016

FDA inspection 988743 · No Action Indicated (NAI) · Anqiu

Key facts

Inspection ID 988743
Firm Topharman Shandong Co., Ltd.
FEI number 3010708767
Address 49 Wenshuibeilu, Economic Development Zone
City Anqiu
Country China
Fiscal year 2016
Inspection end date Sep 28, 2016
Classification No Action Indicated (NAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections